Question 1

Does Trexquant Investment own FDMT stock?

Accepted Answer

No. Trexquant Investment exited its FDMT (4D Molecular Therapeutics in) position in Q1 2026. Its Q4 2025 13F listed 13,229 shares worth $99,218.

Question 2

How many shares of FDMT does Trexquant Investment own?

Accepted Answer

None since Q1 2026, when Trexquant Investment exited the position. Its Q4 2025 13F listed 13,229 shares worth $99,218.

Question 3

What is Trexquant Investment's FDMT position worth?

Accepted Answer

Trexquant Investment's FDMT position was worth $99,218 in its Q4 2025 13F, before the exit in Q1 2026.

Question 4

Is Trexquant Investment buying or selling FDMT?

Accepted Answer

In Q1 2026, Trexquant Investment exited its entire FDMT position.

Question 5

When did Trexquant Investment first buy FDMT?

Accepted Answer

Trexquant Investment first reported FDMT in its Q2 2022 13F and listed it in 7 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$8.46	0
2025-Q4	Decreased	13,229	-83.7%	$99,218	0.0%	$7.58	0
2025-Q3	New	81,354	—	$706,966	0.0%	$8.35	34
2024-Q3	Exited	0	-100.0%	$0	0.0%	$10.83	0